Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918) (SMARTMSP)

What is the purpose of this trial?

Evaluate the effectiveness of Boston Scientific (BSC)'s LV MSP (Left Ventricular MultiSite Pacing) feature in the Resonate family of CRT-D devices1 and confirm safety in a post approval study when used in accordance with its approved labeling.

Participation Guidelines

Ages: 18 years and older

Gender: Both

Boston Scientific Corporation

Start Date: 05/03/2018

End Date: 04/30/2020

Last Updated: 08/15/2018

Study HIC#: 2000021924

Get Involved

For more information about this study, contact:
Margaret Leiss

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 1-877-978-8348.

Trial Image